Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iodofiltic Acid I 123 for Identification of Ischemic Myocardium in ACS
NCT00514501Phase 2Completed
- Sponsor
- Molecular Insights Pharmaceuticals
- Start
- May 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of iodofiltic acid I-123 in acute coronary syndrome (ACS), sponsored by Molecular Insights Pharmaceuticals. Started May 2007; status: completed.
02
Drugs
iodofiltic acid I-123
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00514501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514501.